Astragalus: what the evidence actually says

What it is

Astragalus membranaceus is a perennial legume native to China, Mongolia, and Korea. The dried root (huang qi) is one of the most prescribed botanicals in Traditional Chinese Medicine.

On a supplement label, astragalus appears as dried root powder, root extract (typically standardised to astragalosides or polysaccharides), or — at the high end — as isolated astragaloside IV.

The relevant compounds are astragaloside IV, cycloastragenol, and the astragalus polysaccharides (APS). They are not interchangeable, and the standardisation matters more than the raw extract weight.

What the marketing claims

The phrasing on a supplement label or sales page tends to recycle a few patterns. Astragalus usually shows up wearing one of these:

• "Strengthens the immune system."
• "Anti-aging — protects telomeres."
• "Adaptogen — helps the body resist stress."
• "Supports kidney, liver, and cardiovascular health."

What the published evidence actually says

Astragalus polysaccharides have human trial evidence as adjunct therapy for several conditions, primarily as a chemotherapy adjunct in oncology — meta-analyses suggest reductions in nausea and improved performance status when combined with platinum-based chemotherapy. These are adjunct findings in supervised settings, not over-the-counter wellness claims.

Immune marker effects (NK cell activity, T-cell proliferation, cytokine modulation) are reproducible in cell-culture and animal work and in some small human trials. Translation to "fewer colds" or "stronger immunity" in healthy adults at supplement doses is not well supported.

The telomere claim rests primarily on cycloastragenol and astragaloside IV activating telomerase in cell lines. There is one small commercial human trial reporting telomere length changes; the result has not been independently replicated at a quality threshold the broader research community accepts.

Cardiovascular and renal protection claims have meaningful preclinical support and limited human trial support. Most positive human trials were conducted in China with methodological caveats, and not at the doses used in Western supplements.

Effective dose vs typical supplement dose

Traditional Chinese Medicine doses use 9–30 g of dried root daily, prepared as a decoction.

Trials of astragalus extract (typically standardised to 16–70% polysaccharides or 0.3–0.5% astragaloside IV) have used 250–1,000 mg of standardised extract per day.

Isolated astragaloside IV trials have used 5–40 mg per day. Cycloastragenol trials sit in a similar range.

A tincture or proprietary blend listing astragalus without standardisation or mg almost certainly delivers a milligram-level dose of dried root equivalent — orders of magnitude below the studied immunomodulatory ranges.

Safety profile

Well tolerated at studied doses. Most adverse events are mild gastrointestinal.

Immunomodulatory by design — caution if you are on immunosuppressants, post-transplant, or living with an autoimmune disease. Astragalus can theoretically interfere with both.

May potentiate diuretic effects. Modest interaction with antihypertensive medication.

Pregnancy and breastfeeding: insufficient human safety data on concentrated extracts. Default to avoid.

This is general information, not medical advice. Anyone on prescription medication, pregnant or breastfeeding, or managing a chronic condition should bring an ingredient like Astragalus to their clinician before starting it.